# Clustering Approach 6 : MRNASEQ_CHIERARCHICAL
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.00197686945268816	Range of duration = 0.1 to 98.76, nDeath = 54, nCensor = 56
2	AGE	ANOVA	0.00231908885185539	Range of values = 18 to 90, Mean = 56.6443, StdDev = 16.2191, nMissing = 4
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	1.37073275692282e-11	nTypes = 4 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 27/24/35/112
4	GENDER	Fisher's exact test	0.43317216548638	nTypes = 2 (FEMALE/MALE), nPatients = 75/123
5	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.999999999999882	nTypes = 2 (NO/YES), nPatients = 3/195
6	DISTANT.METASTASIS	Chi-square test	0.440042274076063	nTypes = 5 (M0/M1/M1A/M1B/M1C), nPatients = 172/2/2/2/3, nMissing = 17
7	LYMPH.NODE.METASTASIS	Chi-square test	0.748044280321142	nTypes = 10 (N0/N1/N1A/N1B/N2/N2A/N2B/N2C/N3/NX), nPatients = 109/2/7/17/1/5/13/6/18/5, nMissing = 15
8	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 198
9	NEOPLASM.DISEASESTAGE	Chi-square test	0.000426276484557046	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 4/17/10/15/20/9/10/22/9/6/20/26/7, nMissing = 23